LESLIE COKER: Open Payments
NPI 1275500449 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 24 payments from 11 companies in 2025. Trend: 2023 $116 · 2024 $398 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| UCB, Inc. | 4 | $108 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $78 |
| Amgen Inc. | 3 | $67 |
| Incyte Corporation | 2 | $40 |
| Janssen Biotech, Inc. | 2 | $39 |
| LEO Pharma Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $29 |
| Biofrontera Inc. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
Products named: Bimzelx, OTEZLA, OPZELURA, TREMFYA, Winlevi, ILUMYA, ADBRY, RINVOQ.
Industry payments across VA — which companies pay providers there.
